Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1677 entries
Sorted by: Best Match Show Resources per page
[The Japanese Nursing Association and its outlook for the year 1977].

[Kango] Japanese journal of nursing

Omori F.
PMID: 586372
Kango. 1977 Feb;29(2):4-10.

No abstract available.

Cite
Omori F. [The Japanese Nursing Association and its outlook for the year 1977]. Kango. 1977;29(2):4-10
Omori, F. (1977). [The Japanese Nursing Association and its outlook for the year 1977]. [Kango] Japanese journal of nursing, 29(2), 4-10.
Omori, F. "[The Japanese Nursing Association and its outlook for the year 1977]." [Kango] Japanese journal of nursing vol. 29,2 (1977): 4-10.
Omori F. [The Japanese Nursing Association and its outlook for the year 1977]. Kango. 1977 Feb;29(2):4-10. Japanese. PMID: 586372.
Copy Download .nbib Format: NLM
[Effects of stresses at home and work and social support on the burnout phenomenon in nurses].

Kango kenkyu. The Japanese journal of nursing research

Yamamoto A, Minami H, Ota K, Omori S, Ibe T.
PMID: 3650439
Kango Kenkyu. 1987;20(2):219-30.

No abstract available.

Cite
Yamamoto A, Minami H, Ota K, et al. [Effects of stresses at home and work and social support on the burnout phenomenon in nurses]. Kango Kenkyu. 1987;20(2):219-30
Yamamoto, A., Minami, H., Ota, K., Omori, S., & Ibe, T. (1987). [Effects of stresses at home and work and social support on the burnout phenomenon in nurses]. Kango kenkyu. The Japanese journal of nursing research, 20(2), 219-30.
Yamamoto, A, et al. "[Effects of stresses at home and work and social support on the burnout phenomenon in nurses]." Kango kenkyu. The Japanese journal of nursing research vol. 20,2 (1987): 219-30.
Yamamoto A, Minami H, Ota K, Omori S, Ibe T. [Effects of stresses at home and work and social support on the burnout phenomenon in nurses]. Kango Kenkyu. 1987;20(2):219-30. Japanese. PMID: 3650439.
Copy Download .nbib Format: NLM
[Present status of education in ophthalmology in Japan. I. For students in medical school].

Nippon Ganka Gakkai zasshi

Oyama N, Mori S.
PMID: 5693566
Nippon Ganka Gakkai Zasshi. 1968 Apr 10;72(4):452-60.

No abstract available.

Cite
Oyama N, Mori S. [Present status of education in ophthalmology in Japan. I. For students in medical school]. Nippon Ganka Gakkai Zasshi. 1968;72(4):452-60
Oyama, N., & Mori, S. (1968). [Present status of education in ophthalmology in Japan. I. For students in medical school]. Nippon Ganka Gakkai zasshi, 72(4), 452-60.
Oyama, N, and Mori, S. "[Present status of education in ophthalmology in Japan. I. For students in medical school]." Nippon Ganka Gakkai zasshi vol. 72,4 (1968): 452-60.
Oyama N, Mori S. [Present status of education in ophthalmology in Japan. I. For students in medical school]. Nippon Ganka Gakkai Zasshi. 1968 Apr 10;72(4):452-60. Japanese. PMID: 5693566.
Copy Download .nbib Format: NLM
[Discussion between Dr. Ohlsen and Dr. Elise: a fine example of primary health care--Kochi Prefecture].

[Kango] Japanese journal of nursing

Omori F.
PMID: 243667
Kango. 1977 Aug;29(8):99-102.

No abstract available.

Cite
Omori F. [Discussion between Dr. Ohlsen and Dr. Elise: a fine example of primary health care--Kochi Prefecture]. Kango. 1977;29(8):99-102
Omori, F. (1977). [Discussion between Dr. Ohlsen and Dr. Elise: a fine example of primary health care--Kochi Prefecture]. [Kango] Japanese journal of nursing, 29(8), 99-102.
Omori, F. "[Discussion between Dr. Ohlsen and Dr. Elise: a fine example of primary health care--Kochi Prefecture]." [Kango] Japanese journal of nursing vol. 29,8 (1977): 99-102.
Omori F. [Discussion between Dr. Ohlsen and Dr. Elise: a fine example of primary health care--Kochi Prefecture]. Kango. 1977 Aug;29(8):99-102. Japanese. PMID: 243667.
Copy Download .nbib Format: NLM
[A visit to a district in the People's Republic of China].

[Kango] Japanese journal of nursing

Omori F.
PMID: 253817
Kango. 1979 Feb;31(2):52-9.

No abstract available.

Cite
Omori F. [A visit to a district in the People's Republic of China]. Kango. 1979;31(2):52-9
Omori, F. (1979). [A visit to a district in the People's Republic of China]. [Kango] Japanese journal of nursing, 31(2), 52-9.
Omori, F. "[A visit to a district in the People's Republic of China]." [Kango] Japanese journal of nursing vol. 31,2 (1979): 52-9.
Omori F. [A visit to a district in the People's Republic of China]. Kango. 1979 Feb;31(2):52-9. Japanese. PMID: 253817.
Copy Download .nbib Format: NLM
Monitoring of Blood Vessel Density Using Contrast-Enhanced High Frequency Ultrasound May Facilitate Early Diagnosis of Lymph Node Metastasis.

Journal of Cancer

Sato T, Takemura T, Ouchi T, Mori S, Sakamoto M, Arai Y, Kodama T.
PMID: 28382132
J Cancer. 2017 Feb 25;8(5):704-715. doi: 10.7150/jca.18027. eCollection 2017.

Time-dependent alterations in the ultrasonography characteristics of lymph nodes during early-stage metastasis have not been compared with those of tumor-draining lymph nodes that do not develop tumor; this is partly due to the absence of an appropriate experimental model....

Cite
Sato T, Takemura T, Ouchi T, et al. Monitoring of Blood Vessel Density Using Contrast-Enhanced High Frequency Ultrasound May Facilitate Early Diagnosis of Lymph Node Metastasis. J Cancer. 2017;8(5):704-715doi: 10.7150/jca.18027.
Sato, T., Takemura, T., Ouchi, T., Mori, S., Sakamoto, M., Arai, Y., & Kodama, T. (2017). Monitoring of Blood Vessel Density Using Contrast-Enhanced High Frequency Ultrasound May Facilitate Early Diagnosis of Lymph Node Metastasis. Journal of Cancer, 8(5), 704-715. https://doi.org/10.7150/jca.18027
Sato, Takuma, et al. "Monitoring of Blood Vessel Density Using Contrast-Enhanced High Frequency Ultrasound May Facilitate Early Diagnosis of Lymph Node Metastasis." Journal of Cancer vol. 8,5 (2017): 704-715. doi: https://doi.org/10.7150/jca.18027
Sato T, Takemura T, Ouchi T, Mori S, Sakamoto M, Arai Y, Kodama T. Monitoring of Blood Vessel Density Using Contrast-Enhanced High Frequency Ultrasound May Facilitate Early Diagnosis of Lymph Node Metastasis. J Cancer. 2017 Feb 25;8(5):704-715. doi: 10.7150/jca.18027. eCollection 2017. PMID: 28382132; PMCID: PMC5381158.
Copy Download .nbib Format: NLM
Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis.

Clinical medicine insights. Circulatory, respiratory and pulmonary medicine

Mori S.
PMID: 26401101
Clin Med Insights Circ Respir Pulm Med. 2015 Sep 08;9:41-9. doi: 10.4137/CCRPM.S23288. eCollection 2015.

Interstitial lung disease (ILD) is one of the major causes of morbidity and mortality of patients with rheumatoid arthritis (RA). Accompanying the increased number of reports on the development or exacerbation of ILD in RA patients following therapy with...

Cite
Mori S. Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis. Clin Med Insights Circ Respir Pulm Med. 2015;9:41-9doi: 10.4137/CCRPM.S23288.
Mori, S. (2015). Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis. Clinical medicine insights. Circulatory, respiratory and pulmonary medicine, 941-9. https://doi.org/10.4137/CCRPM.S23288
Mori, Shunsuke. "Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis." Clinical medicine insights. Circulatory, respiratory and pulmonary medicine vol. 9 (2015): 41-9. doi: https://doi.org/10.4137/CCRPM.S23288
Mori S. Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis. Clin Med Insights Circ Respir Pulm Med. 2015 Sep 08;9:41-9. doi: 10.4137/CCRPM.S23288. eCollection 2015. PMID: 26401101; PMCID: PMC4564070.
Copy Download .nbib Format: NLM
Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations.

Clinical medicine insights. Circulatory, respiratory and pulmonary medicine

Mori S, Sugimoto M.
PMID: 26396551
Clin Med Insights Circ Respir Pulm Med. 2015 Sep 06;9:29-40. doi: 10.4137/CCRPM.S23286. eCollection 2015.

Pneumocystis jirovecii infection causes fulminant interstitial pneumonia (Pneumocystis pneumonia, PCP) in patients with rheumatoid arthritis (RA) who are receiving biological and/or nonbiological antirheumatic drugs. Recently, we encountered a PCP outbreak among RA outpatients at our institution. Hospital-acquired, person-to-person transmission...

Cite
Mori S, Sugimoto M. Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations. Clin Med Insights Circ Respir Pulm Med. 2015;9:29-40doi: 10.4137/CCRPM.S23286.
Mori, S., & Sugimoto, M. (2015). Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations. Clinical medicine insights. Circulatory, respiratory and pulmonary medicine, 929-40. https://doi.org/10.4137/CCRPM.S23286
Mori, Shunsuke, and Sugimoto, Mineharu. "Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations." Clinical medicine insights. Circulatory, respiratory and pulmonary medicine vol. 9 (2015): 29-40. doi: https://doi.org/10.4137/CCRPM.S23286
Mori S, Sugimoto M. Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations. Clin Med Insights Circ Respir Pulm Med. 2015 Sep 06;9:29-40. doi: 10.4137/CCRPM.S23286. eCollection 2015. PMID: 26396551; PMCID: PMC4562607.
Copy Download .nbib Format: NLM
Continuous in vivo culture and indirect fluorescent antibody test for zoonotic protozoa of Babesia microti.

Parasitology international

Saito-Ito A, Kawai A, Ohmori S, Nagano-Fujii M.
PMID: 27033029
Parasitol Int. 2016 Oct;65(5):526-531. doi: 10.1016/j.parint.2016.03.007. Epub 2016 Mar 24.

Babesiosis has attracted attention as a zoonotic disease. The disease is caused in immunocompetent individuals almost solely by Babesia microti, a rodent babesia. Most cases of human babesiosis by B. microti have been reported in the endemic foci of...

Cite
Saito-Ito A, Kawai A, Ohmori S, et al. Continuous in vivo culture and indirect fluorescent antibody test for zoonotic protozoa of Babesia microti. Parasitol Int. 2016;65(5):526-531doi: 10.1016/j.parint.2016.03.007.
Saito-Ito, A., Kawai, A., Ohmori, S., & Nagano-Fujii, M. (2016). Continuous in vivo culture and indirect fluorescent antibody test for zoonotic protozoa of Babesia microti. Parasitology international, 65(5), 526-531. https://doi.org/10.1016/j.parint.2016.03.007
Saito-Ito, Atsuko, et al. "Continuous in vivo culture and indirect fluorescent antibody test for zoonotic protozoa of Babesia microti." Parasitology international vol. 65,5 (2016): 526-531. doi: https://doi.org/10.1016/j.parint.2016.03.007
Saito-Ito A, Kawai A, Ohmori S, Nagano-Fujii M. Continuous in vivo culture and indirect fluorescent antibody test for zoonotic protozoa of Babesia microti. Parasitol Int. 2016 Oct;65(5):526-531. doi: 10.1016/j.parint.2016.03.007. Epub 2016 Mar 24. PMID: 27033029.
Copy Download .nbib Format: NLM
AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy.

Journal of nephropathology

Moradi M, Rahimi Z, Amiri S, Rahimi Z, Vessal M, Nasri H.
PMID: 26310144
J Nephropathol. 2015 Jul;4(3):69-76. doi: 10.12860/jnp.2015.14. Epub 2015 Jul 01.

BACKGROUND: There are inconsistent reports related to the role of angiotensin II type 1 receptor (AT1R) on the risk of type 2 diabetes mellitus (T2DM) and its renal complications.OBJECTIVES: To identify the association between AT1R A1166C variants with the...

Cite
Moradi M, Rahimi Z, Amiri S, et al. AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy. J Nephropathol. 2015;4(3):69-76doi: 10.12860/jnp.2015.14.
Moradi, M., Rahimi, Z., Amiri, S., Rahimi, Z., Vessal, M., & Nasri, H. (2015). AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy. Journal of nephropathology, 4(3), 69-76. https://doi.org/10.12860/jnp.2015.14
Moradi, Mahmoudreza, et al. "AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy." Journal of nephropathology vol. 4,3 (2015): 69-76. doi: https://doi.org/10.12860/jnp.2015.14
Moradi M, Rahimi Z, Amiri S, Rahimi Z, Vessal M, Nasri H. AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy. J Nephropathol. 2015 Jul;4(3):69-76. doi: 10.12860/jnp.2015.14. Epub 2015 Jul 01. PMID: 26310144; PMCID: PMC4544557.
Copy Download .nbib Format: NLM
Benzo[c,d]indole-Containing Aza-BODIPY Dyes: Asymmetrization-Induced Solid-State Emission and Aggregation-Induced Emission Enhancement as New Properties of a Well-Known Chromophore.

Chemistry (Weinheim an der Bergstrasse, Germany)

Shimizu S, Murayama A, Haruyama T, Iino T, Mori S, Furuta H, Kobayashi N.
PMID: 26212774
Chemistry. 2015 Sep 07;21(37):12996-3003. doi: 10.1002/chem.201501464. Epub 2015 Jul 17.

A series of symmetric and asymmetric benzo[c,d]indole-containing aza boron dipyrromethene (aza-BODIPY) compounds was synthesized by a titanium tetrachloride-mediated Schiff-base formation reaction of commercially available benzo[c,d]indole-2(1H)-one and heteroaromatic amines. These aza-BODIPY analogues show different electronic structures from those of regular...

Cite
Shimizu S, Murayama A, Haruyama T, et al. Benzo[c,d]indole-Containing Aza-BODIPY Dyes: Asymmetrization-Induced Solid-State Emission and Aggregation-Induced Emission Enhancement as New Properties of a Well-Known Chromophore. Chemistry. 2015;21(37):12996-3003doi: 10.1002/chem.201501464.
Shimizu, S., Murayama, A., Haruyama, T., Iino, T., Mori, S., Furuta, H., & Kobayashi, N. (2015). Benzo[c,d]indole-Containing Aza-BODIPY Dyes: Asymmetrization-Induced Solid-State Emission and Aggregation-Induced Emission Enhancement as New Properties of a Well-Known Chromophore. Chemistry (Weinheim an der Bergstrasse, Germany), 21(37), 12996-3003. https://doi.org/10.1002/chem.201501464
Shimizu, Soji, et al. "Benzo[c,d]indole-Containing Aza-BODIPY Dyes: Asymmetrization-Induced Solid-State Emission and Aggregation-Induced Emission Enhancement as New Properties of a Well-Known Chromophore." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 21,37 (2015): 12996-3003. doi: https://doi.org/10.1002/chem.201501464
Shimizu S, Murayama A, Haruyama T, Iino T, Mori S, Furuta H, Kobayashi N. Benzo[c,d]indole-Containing Aza-BODIPY Dyes: Asymmetrization-Induced Solid-State Emission and Aggregation-Induced Emission Enhancement as New Properties of a Well-Known Chromophore. Chemistry. 2015 Sep 07;21(37):12996-3003. doi: 10.1002/chem.201501464. Epub 2015 Jul 17. PMID: 26212774.
Copy Download .nbib Format: NLM
Evaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-up.

Journal of diabetes and metabolic disorders

Nasli-Esfahani E, Ghodsi M, Amini P, Keshtkar AA, Amiri S, Mojahed-Yazdi N, Tootee A, Larijani B.
PMID: 26207222
J Diabetes Metab Disord. 2015 Apr 22;14:33. doi: 10.1186/s40200-014-0126-x. eCollection 2015.

BACKGROUND: Rapidly increasing prevalence of diabetes throughout the world highlights the importance of looking for new treatment options for the disease such as stem cell therapy. With regard to the increasing attention towards stem-cell therapy as a curative treatment...

Cite
Nasli-Esfahani E, Ghodsi M, Amini P, et al. Evaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-up. J Diabetes Metab Disord. 2015;14:33doi: 10.1186/s40200-014-0126-x.
Nasli-Esfahani, E., Ghodsi, M., Amini, P., Keshtkar, A. A., Amiri, S., Mojahed-Yazdi, N., Tootee, A., & Larijani, B. (2015). Evaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-up. Journal of diabetes and metabolic disorders, 1433. https://doi.org/10.1186/s40200-014-0126-x
Nasli-Esfahani, Ensieh, et al. "Evaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-up." Journal of diabetes and metabolic disorders vol. 14 (2015): 33. doi: https://doi.org/10.1186/s40200-014-0126-x
Nasli-Esfahani E, Ghodsi M, Amini P, Keshtkar AA, Amiri S, Mojahed-Yazdi N, Tootee A, Larijani B. Evaluation of fetal cell transplantation safety in treatment of diabetes: a three-year follow-up. J Diabetes Metab Disord. 2015 Apr 22;14:33. doi: 10.1186/s40200-014-0126-x. eCollection 2015. PMID: 26207222; PMCID: PMC4511990.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1677 entries